CD21 (CR2) RNA expression was detected in 80% (210 of 264) of T-ALL cases in a published pediatric cohort (Fig. 1B), across all molecular subtypes (Fig. 1C) (17). The gene discussed is CR2; the disease is acute lymphoblastic leukemia.